Miracle Mile Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Miracle Mile Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,400	Closed	-$10.2K	–	1028
2026 Q1	$10.2K	Hold	41,400	–	–	﹤0.01%	890
2025 Q4	$17.4K	Buy	41,400 +100	+0.2%	+$53	﹤0.01%	864
2025 Q3	$27.8K	Hold	41,300	–	–	﹤0.01%	823
2025 Q2	$22.4K	Hold	41,300	–	–	﹤0.01%	717
2025 Q1	$27.1K	Hold	41,300	–	–	﹤0.01%	639
2024 Q4	$42.1K	Hold	41,300	–	–	﹤0.01%	628
2024 Q3	$35.8K	Hold	41,300	–	–	﹤0.01%	521
2024 Q2	$14.8K	Hold	41,300	–	–	﹤0.01%	501
2024 Q1	$27.7K	Hold	41,300	–	–	﹤0.01%	499
2023 Q4	$22.4K	Hold	41,300	–	–	﹤0.01%	485
2023 Q3	$24.8K	Buy	+41,300	New	+$44.2K	﹤0.01%	478

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Miracle Mile Advisors's SGMO Position: Q2 2026 in Review

Miracle Mile Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 41,400 shares — an estimated $10.2K sold.

Miracle Mile Advisors first reported a position in SGMO in Q3 2023 and held it in 11 quarters. The position peaked at $42.1K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Miracle Mile Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Miracle Mile Advisors sold 41,400 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $10.2K.
Miracle Mile Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q3 2023 and held it in 11 quarters.
Miracle Mile Advisors's SANGAMO THERAPEUTICS INC position peaked at $42.1K in Q4 2024.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.